Literature DB >> 17196331

Distribution and cellular localization of high mobility group box protein 1 (HMGB1) in the spinal cord of a transgenic mouse model of ALS.

Daniele Lo Coco1, Pietro Veglianese, Elisa Allievi, Caterina Bendotti.   

Abstract

Although the aetiology of amyotrophic lateral sclerosis (ALS) is still elusive, increased attention has been put forward on events related to neuroinflammation and an active participation of glial cells in the ALS pathogenesis has been suggested. However, the specific role of many proinflammatory mediators that usually accompany the inflammatory changes is still largely unknown. High mobility group box protein 1 (HMGB1) is an ubiquitous nuclear protein that exerts numerous extranuclear and extracellular functions, including a proinflammatory activity, able to induce cytokines expression and activate inflammatory cells. To investigate whether this protein may play a role in the inflammatory events in ALS, we examined both expression and localization of HMGB1 in the lumbar spinal cord of SOD1G93A transgenic mice, a well established mouse model of familial ALS, at different stages of the disease. Intense HMGB1 reactivity was detected in ventral horn motor neurons of both non-transgenic and SOD1G93A mice and there was no difference in its expression between presymptomatic SOD1G93A mice and controls. With the progression of the disease, degenerating neurons showed a reduction of HMGB1 immunoreactivity which could reflect an extracellular release of this protein. By contrast, in the reactive glial cells HMGB1 was remarkably expressed in the nucleus, but not in the cytosol, likely contributing to the proliferation and/or hypertrophy of these cells. These results suggest that HMGB1 may have a different involvement in the motor neurons and glial cells in response to the neurotoxic environment in the spinal cord of SOD1G93A mice, and it may contribute to the progression of inflammatory and neurodegenerative processes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17196331     DOI: 10.1016/j.neulet.2006.10.063

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  27 in total

Review 1.  NLRs as Helpline in the Brain: Mechanisms and Therapeutic Implications.

Authors:  Shalini Singh; Sushmita Jha
Journal:  Mol Neurobiol       Date:  2018-03-06       Impact factor: 5.590

2.  HMGB1 Mediates Paraquat-Induced Neuroinflammatory Responses via Activating RAGE Signaling Pathway.

Authors:  Min Huang; Muzhen Guo; Kai Wang; Kexin Wu; Yingying Li; Tian Tian; Yifan Wang; Weiguang Yan; Zhijun Zhou; Huifang Yang
Journal:  Neurotox Res       Date:  2019-12-20       Impact factor: 3.911

Review 3.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

Review 4.  HMGB1 in development and diseases of the central nervous system.

Authors:  Ping Fang; Melitta Schachner; Yan-Qin Shen
Journal:  Mol Neurobiol       Date:  2012-05-13       Impact factor: 5.590

5.  High-mobility group box 1 protein (HMGB1) neutralization ameliorates experimental autoimmune encephalomyelitis.

Authors:  Andrew P Robinson; Matthew W Caldis; Christopher T Harp; Gwendolyn E Goings; Stephen D Miller
Journal:  J Autoimmun       Date:  2013-03-17       Impact factor: 7.094

6.  Cortical Neurotoxic Astrocytes with Early ALS Pathology and miR-146a Deficit Replicate Gliosis Markers of Symptomatic SOD1G93A Mouse Model.

Authors:  Cátia Gomes; Carolina Cunha; Filipe Nascimento; Joaquim A Ribeiro; Ana Rita Vaz; Dora Brites
Journal:  Mol Neurobiol       Date:  2018-07-11       Impact factor: 5.590

7.  Long noncoding RNA BS-DRL1 modulates the DNA damage response and genome stability by interacting with HMGB1 in neurons.

Authors:  Min-Min Lou; Xiao-Qiang Tang; Guang-Ming Wang; Jia He; Fang Luo; Ming-Feng Guan; Fei Wang; Huan Zou; Jun-Ying Wang; Qun Zhang; Ming-Jian Xu; Qi-Li Shi; Li-Bing Shen; Guo-Ming Ma; Yi Wu; Yao-Yang Zhang; Ai-Bin Liang; Ting-Hua Wang; Liu-Lin Xiong; Jian Wang; Jun Xu; Wen-Yuan Wang
Journal:  Nat Commun       Date:  2021-07-01       Impact factor: 14.919

8.  Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1G93A murine model of amyotrophic lateral sclerosis in a sex-dependent manner.

Authors:  Michael MacLean; Judyta Juranek; Swetha Cuddapah; Raquel López-Díez; Henry H Ruiz; Jiyuan Hu; Laura Frye; Huilin Li; Paul F Gugger; Ann Marie Schmidt
Journal:  J Neuroinflammation       Date:  2021-06-15       Impact factor: 8.322

9.  Eosinophil-derived neurotoxin is elevated in patients with amyotrophic lateral sclerosis.

Authors:  Guan-Ting Liu; Chi-Shin Hwang; Chia-Hung Hsieh; Chih-Hao Lu; Sunny Li-Yun Chang; Jin-Ching Lee; Chien-Fu Huang; Hao-Teng Chang
Journal:  Mediators Inflamm       Date:  2013-02-20       Impact factor: 4.711

Review 10.  Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact.

Authors:  Fabiola De Marchi; Ivana Munitic; Amedeo Amedei; James D Berry; Eva L Feldman; Eleonora Aronica; Giovanni Nardo; Donatienne Van Weehaeghe; Elena Niccolai; Nikolina Prtenjaca; Stacey A Sakowski; Caterina Bendotti; Letizia Mazzini
Journal:  Neurosci Biobehav Rev       Date:  2021-06-19       Impact factor: 9.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.